Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells - PubMed (original) (raw)
Review
Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells
G J Wiederrecht et al. Prog Cell Cycle Res. 1995.
Abstract
The immunosuppressant drug, rapamycin (RAP), is a potent inhibitor of IL-2-dependent T-cell proliferation. The antiproliferative effect of RAP is mediated through the formation of an active complex with its cytosolic receptor protein, FKBP12. The molecular target of the FKBP12.RAP complex is a putative lipid kinase termed the mammalian Target Of Rapamycin (mTOR). This review will discuss recent findings suggesting that mTOR is a novel regulator of G1- to S-phase progression in eukaryotic cells.
Similar articles
- Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT. Sabers CJ, et al. J Biol Chem. 1995 Jan 13;270(2):815-22. doi: 10.1074/jbc.270.2.815. J Biol Chem. 1995. PMID: 7822316 - Mechanism of action of the immunosuppressant rapamycin.
Dumont FJ, Su Q. Dumont FJ, et al. Life Sci. 1996;58(5):373-95. doi: 10.1016/0024-3205(95)02233-3. Life Sci. 1996. PMID: 8594303 Review. - Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling.
Abraham RT. Abraham RT. Curr Opin Immunol. 1998 Jun;10(3):330-6. doi: 10.1016/s0952-7915(98)80172-6. Curr Opin Immunol. 1998. PMID: 9638370 Review. - A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL. Brown EJ, et al. Nature. 1994 Jun 30;369(6483):756-8. doi: 10.1038/369756a0. Nature. 1994. PMID: 8008069 - TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
Zheng XF, Florentino D, Chen J, Crabtree GR, Schreiber SL. Zheng XF, et al. Cell. 1995 Jul 14;82(1):121-30. doi: 10.1016/0092-8674(95)90058-6. Cell. 1995. PMID: 7606777
Cited by
- mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells.
Easley CA 4th, Ben-Yehudah A, Redinger CJ, Oliver SL, Varum ST, Eisinger VM, Carlisle DL, Donovan PJ, Schatten GP. Easley CA 4th, et al. Cell Reprogram. 2010 Jun;12(3):263-73. doi: 10.1089/cell.2010.0011. Cell Reprogram. 2010. PMID: 20698768 Free PMC article. - Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.
Samidurai A, Kukreja RC, Das A. Samidurai A, et al. Oxid Med Cell Longev. 2018 Aug 23;2018:6141902. doi: 10.1155/2018/6141902. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30305865 Free PMC article. Review. - The inhibitory effect of rapamycin on the oval cell response and development of preneoplastic foci in the rat.
Sanders JA, Brilliant KE, Clift D, Patel A, Cerretti B, Claro P, Mills DR, Hixson DC, Gruppuso PA. Sanders JA, et al. Exp Mol Pathol. 2012 Aug;93(1):40-9. doi: 10.1016/j.yexmp.2012.04.002. Epub 2012 Apr 16. Exp Mol Pathol. 2012. PMID: 22525806 Free PMC article. - mTOR controls ovarian follicle growth by regulating granulosa cell proliferation.
Yu J, Yaba A, Kasiman C, Thomson T, Johnson J. Yu J, et al. PLoS One. 2011;6(7):e21415. doi: 10.1371/journal.pone.0021415. Epub 2011 Jul 5. PLoS One. 2011. PMID: 21750711 Free PMC article. - Targeted therapy for sarcomas.
Forscher C, Mita M, Figlin R. Forscher C, et al. Biologics. 2014 Mar 17;8:91-105. doi: 10.2147/BTT.S26555. eCollection 2014. Biologics. 2014. PMID: 24669185 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Miscellaneous